Combination of body mass index and albumin predicts the survival in metastatic castration‐resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials

BACKGROUND: Low body mass index (BMI) and low serum albumin levels are suggested indicators of malnutrition and are associated with poor outcomes in cancer patients. Decreasing androgen can alter lipid metabolism, so the prognostic value of BMI may change in metastatic castration‐resistant prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jian, Wang, Jun, Wei, Yu, Zhang, Tingwei, Zhang, Sheng, Ye, Dingwei, Zhu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495267/
https://www.ncbi.nlm.nih.gov/pubmed/34414685
http://dx.doi.org/10.1002/cam4.4205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495267/
https://www.ncbi.nlm.nih.gov/pubmed/34414685
http://dx.doi.org/10.1002/cam4.4205

Ejemplares similares